Patent Assignment
Reel/Frame 070629/0798
Second Lien Intellectual Property Security Agreement
Recorded: 2025-03-26
Pages: 9
Assignors
BAUSCH HEALTH IRELAND LIMITED
Executed: 2025-03-12
SALIX PHARMACEUTICALS, INC.
Executed: 2025-03-12
Assignee
THE BANK OF NEW YORK MELLON
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(2)
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Application:
18/935,127 →
Publication:
US 2025/0171497
Solid Dispersion Forms of Rifaximin
Application:
18/958,759 →
Publication:
US 2025/0082616
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Mar 26, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 070629/0756 →
Intellectual Property Security Agreement
Mar 26, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 070629/0776 →
Release of Security Interest
Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Security Interest
Oct 7, 2025
From: BAUSCH HEALTH IRELAND LIMITED; SALIX PHARMACEUTICALS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 072495/0656 →
Assignment of Assignor's Interest
Nov 20, 2025
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 072971/0624 →
Assignment of Assignor's Interest
Nov 20, 2025
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 072971/0589 →
U.S. Patent Security Agreement Supplement
Nov 25, 2025
From: SALIX PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0409 →
U.S. Patent Security Agreement
Nov 25, 2025
From: BAUSCH HEALTH IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0375 →